Frontier Clinical Research

Uniontown, Pennsylvania 15401

2 studies enrolling now · 5 studies all time

What they study most

Advanced Adenomas (AA), C. Diff Infection, C.Difficile Diarrhea, CDI, Clostridioides Difficile Infection, Clostridioides Difficile Infection Recurrence, Clostridium Difficile, Clostridium Difficile Infection Recurrence, Clostridium Difficile Infections, Colitis, Ulcerative, Colorectal Cancer (CRC), Crohn Disease

Studies at this site

• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• VE303 for Prevention of Recurrent Clostridioides Difficile Infection — Recruiting now
• Collection of Samples USOPTIVAL Study — Recruiting now
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling